Hos patienter, der udvikler reaktivering af HBV, bør Trudexa stoppes og effektiv anti- viral behandling med passende understøttende behandling bør initieres. ke
In patients who develop HBV reactivation, Trudexa should be stopped and effective anti-viral therapy with appropriate supportive treatment should be initiated. lP